MedTrace Logo

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1715

Last updated 2026-04-01

No results posted yet for this study

Summary

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.

Conditions

Interventions

OTHER

Physical exam

Part 2 participants will be prospectively followed clinically for relapse for 30 months from the date of surgery for physical examination at post-ops visits.

Sponsors & Collaborators

Principal Investigators

  • Nadeem Abu-Rustum, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2027-02-26
Completion
2027-02-26

Countries

  • United States
  • Czechia
  • Italy
  • Norway

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04291612 on ClinicalTrials.gov